maximum weight loss tirzepatide surmount trials reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism Tirzepatide Was Associated with Improved

Enhancing its appeal among patients dealing with obesity-related health issues or those susceptible to major adverse cardiovascular events

Lessons Learned: This case illustrates the broad differential diagnosis of AKI and emphasizes the importance of early consideration of drug-induced AIN, even in the absence of classic hypersensitivity findings

Ordinarily, in someone who has not lost weight on Ozempic-type drugs, if theres a complication [related to healing] after surgery, we see it as early as week two, and we tend to see good healing between weeks four and six. But for GLP-1 patients, incisions will sometimes reopen in spots

BodySites program is fully customizable, allowing healthcare providers to tailor the plan to their practice needs and edit as they see fit